Intrinsic Value of S&P & Nasdaq Contact Us

Aptorum Group Limited APM NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • GB • USD

SharesGrow Score
39/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Aptorum Group Limited (APM) has a negative trailing P/E of -4.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 0.3 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -22.61%, forward earnings yield 322.58%.

Criteria proven by this page:

  • VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -4.4); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -22.61%).
  • Forward P/E 0.3 — analysts expect a return to profitability with estimated EPS of $3.10 for FY2026.
  • Trailing Earnings Yield -22.61% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 322.58% as earnings recover.

Overall SharesGrow Score: 37/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
39/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
6/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — APM

Valuation Multiples
P/E (TTM)-4.4
Forward P/E0.3
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.26
P/S Ratio0.00
EV/EBITDA-2.9
Per Share Data
EPS (TTM)$-0.19
Forward EPS (Est.)$3.10
Book Value / Share$1.88
Revenue / Share$0.00
FCF / Share$0.01
Yields & Fair Value
Earnings Yield-22.61%
Forward Earnings Yield322.58%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2017 -169.7 0.00 14.29 0.00 -
2018 -28.6 -0.05 12.79 1,104.90 -
2019 -24.6 -1.20 28.10 859.19 -
2020 10.9 -0.08 1.84 84.38 0.98%
2021 -2.1 0.00 2.23 34.08 -
2022 -2.0 0.03 1.25 15.15 -
2023 -3.9 0.05 0.45 25.68 -
2024 -3.6 -0.14 0.72 0.00 -
2025 -5.7 0.08 0.34 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2017 $-0.85 $0.00 $-2.55M -
2018 $-5.31 $383.45K $-14.83M -3868%
2019 $-6.40 $535.17K $-18.69M -3491.8%
2020 $2.00 $911.51K $7.07M 775.3%
2021 $-7.15 $1.54M $-25.05M -1624.4%
2022 $-2.75 $1.3M $-9.8M -756.2%
2023 $-0.62 $431.38K $-2.83M -654.9%
2024 $-0.78 $0.00 $-4.27M -
2025 $-0.19 $0.00 $-1.36M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $3.10 $3.10 – $3.10 $106.8M $106.8M – $106.8M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message